Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.

Development of an effective vaccine against human cytomegalovirus (HCMV) is a need of utmost medical importance. Generally, it is believed that a live attenuated vaccine would best provide protective immunity against this tenacious pathogen. Here, we propose a strategy for an HCMV vaccine that aims...

Full description

Saved in:
Bibliographic Details
Main Authors: Adriana Tomić, Pavankumar R Varanasi, Mijo Golemac, Suzana Malić, Peggy Riese, Eva M Borst, Eva Mischak-Weissinger, Carlos A Guzmán, Astrid Krmpotić, Stipan Jonjić, Martin Messerle
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-12-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006015&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850231991834771456
author Adriana Tomić
Pavankumar R Varanasi
Mijo Golemac
Suzana Malić
Peggy Riese
Eva M Borst
Eva Mischak-Weissinger
Carlos A Guzmán
Astrid Krmpotić
Stipan Jonjić
Martin Messerle
author_facet Adriana Tomić
Pavankumar R Varanasi
Mijo Golemac
Suzana Malić
Peggy Riese
Eva M Borst
Eva Mischak-Weissinger
Carlos A Guzmán
Astrid Krmpotić
Stipan Jonjić
Martin Messerle
author_sort Adriana Tomić
collection DOAJ
description Development of an effective vaccine against human cytomegalovirus (HCMV) is a need of utmost medical importance. Generally, it is believed that a live attenuated vaccine would best provide protective immunity against this tenacious pathogen. Here, we propose a strategy for an HCMV vaccine that aims at the simultaneous activation of innate and adaptive immune responses. An HCMV strain expressing the host ligand ULBP2 for the NKG2D receptor was found to be susceptible to control by natural killer (NK) cells, and preserved the ability to stimulate HCMV-specific T cells. Infection with the ULBP2-expressing HCMV strain caused diminished cell surface levels of MHC class I molecules. While expression of the NKG2D ligand increased the cytolytic activity of NK cells, NKG2D engagement in CD8+ T cells provided co-stimulation and compensated for lower MHC class I expression. Altogether, our data indicate that triggering of both arms of the immune system is a promising approach applicable to the generation of a live attenuated HCMV vaccine.
format Article
id doaj-art-84d62115fc0a45c8b0f013b940cf52d3
institution OA Journals
issn 1553-7366
1553-7374
language English
publishDate 2016-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-84d62115fc0a45c8b0f013b940cf52d32025-08-20T02:03:19ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742016-12-011212e100601510.1371/journal.ppat.1006015Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.Adriana TomićPavankumar R VaranasiMijo GolemacSuzana MalićPeggy RieseEva M BorstEva Mischak-WeissingerCarlos A GuzmánAstrid KrmpotićStipan JonjićMartin MesserleDevelopment of an effective vaccine against human cytomegalovirus (HCMV) is a need of utmost medical importance. Generally, it is believed that a live attenuated vaccine would best provide protective immunity against this tenacious pathogen. Here, we propose a strategy for an HCMV vaccine that aims at the simultaneous activation of innate and adaptive immune responses. An HCMV strain expressing the host ligand ULBP2 for the NKG2D receptor was found to be susceptible to control by natural killer (NK) cells, and preserved the ability to stimulate HCMV-specific T cells. Infection with the ULBP2-expressing HCMV strain caused diminished cell surface levels of MHC class I molecules. While expression of the NKG2D ligand increased the cytolytic activity of NK cells, NKG2D engagement in CD8+ T cells provided co-stimulation and compensated for lower MHC class I expression. Altogether, our data indicate that triggering of both arms of the immune system is a promising approach applicable to the generation of a live attenuated HCMV vaccine.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006015&type=printable
spellingShingle Adriana Tomić
Pavankumar R Varanasi
Mijo Golemac
Suzana Malić
Peggy Riese
Eva M Borst
Eva Mischak-Weissinger
Carlos A Guzmán
Astrid Krmpotić
Stipan Jonjić
Martin Messerle
Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
PLoS Pathogens
title Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
title_full Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
title_fullStr Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
title_full_unstemmed Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
title_short Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand.
title_sort activation of innate and adaptive immunity by a recombinant human cytomegalovirus strain expressing an nkg2d ligand
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1006015&type=printable
work_keys_str_mv AT adrianatomic activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT pavankumarrvaranasi activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT mijogolemac activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT suzanamalic activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT peggyriese activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT evamborst activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT evamischakweissinger activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT carlosaguzman activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT astridkrmpotic activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT stipanjonjic activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand
AT martinmesserle activationofinnateandadaptiveimmunitybyarecombinanthumancytomegalovirusstrainexpressingannkg2dligand